Gujarat Inject Kerala files FY26 annual report with BSE
- Gujarat Inject Kerala Ltd filed its FY26 annual report with BSE on September 7, 2026
- Filing made pursuant to Regulation 34 of SEBI LODR Regulations, 2015
- Hardikkumar Anilbhai Radadiya appointed CFO effective August 10, 2026
- Murli Shivshankaran Nair continues as Chairman and Whole-time Director

*this image is generated using AI for illustrative purposes only.
Gujarat Inject (Kerala) Ltd has filed its annual report for the financial year 2025-26 with the Bombay Stock Exchange. The submission, dated September 7, 2026, complies with SEBI listing regulations and provides an update on the company’s corporate governance structure.
The filing serves as a formal intimation under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The complete document is available on the company’s official website for investor review.
Board Composition Updates
The annual report details changes in the Board of Directors and Key Managerial Personnel as of March 31, 2026, and subsequent updates.
Murli Shivshankaran Nair continues to serve as Chairman and Whole-time Director. The board includes Non-Executive Independent Directors Rushiraj Zaverbhai Patel, Nileshbhai Vinubhai Rangholiya, and Deepak Diwan Bachwani. Ila Sunil Trivedi is listed as an Additional Non-Executive Independent Director.
Key Personnel Changes
Hardikkumar Anilbhai Radadiya assumed the role of Chief Financial Officer effective August 10, 2026, succeeding Murli Nair. Manmeetkaur Harshdeepsingh Bhatia remains the Company Secretary and Compliance Officer, a position she has held since June 10, 2024.
Committee Structure
The Audit Committee is chaired by Rushiraj Zaverbhai Patel, with Murli Shivshankaran Nair and Nileshbhai Vinubhai Rangholiya serving as members. The Nomination & Remuneration Committee is also chaired by Rushiraj Zaverbhai Patel, comprising Nileshbhai Vinubhai Rangholiya and Deepak Diwan Bachwani as members.
Historical Stock Returns for Gujarat Inject Kerala
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.35% | -5.36% | +20.59% | +71.63% | +421.43% | 0.0% |
How might the transition of CFO duties from the Chairman to Hardikkumar Radadiya impact Gujarat Inject's financial strategy and operational oversight?
What are the expected implications of Ila Sunil Trivedi's appointment as an Additional Non-Executive Independent Director on the board's decision-making dynamics?
How will the new leadership structure influence Gujarat Inject's compliance posture and risk management in the coming fiscal year?



























